Modeling Dynamics of Cell-to-Cell Variability in TRAIL-Induced Apoptosis Explains Fractional Killing and Predicts Reversible Resistance

Isogenic cells sensing identical external signals can take markedly different decisions. Such decisions often correlate with pre-existing cell-to-cell differences in protein levels. When not neglected in signal transduction models, these differences are accounted for in a static manner, by assuming randomly distributed initial protein levels. However, this approach ignores the a priori non-trivial interplay between signal transduction and the source of this cell-to-cell variability: temporal fluctuations of protein levels in individual cells, driven by noisy synthesis and degradation. Thus, modeling protein fluctuations, rather than their consequences on the initial population heterogeneity, would set the quantitative analysis of signal transduction on firmer grounds. Adopting this dynamical view on cell-to-cell differences amounts to recast extrinsic variability into intrinsic noise. Here, we propose a generic approach to merge, in a systematic and principled manner, signal transduction models with stochastic protein turnover models. When applied to an established kinetic model of TRAIL-induced apoptosis, our approach markedly increased model prediction capabilities. One obtains a mechanistic explanation of yet-unexplained observations on fractional killing and non-trivial robust predictions of the temporal evolution of cell resistance to TRAIL in HeLa cells. Our results provide an alternative explanation to survival via induction of survival pathways since no TRAIL-induced regulations are needed and suggest that short-lived anti-apoptotic protein Mcl1 exhibit large and rare fluctuations. More generally, our results highlight the importance of accounting for stochastic protein turnover to quantitatively understand signal transduction over extended durations, and imply that fluctuations of short-lived proteins deserve particular attention.

[1]  O. Micheau,et al.  Targeting c-FLIP in cancer. , 2013, Cancer letters.

[2]  L. Hood,et al.  Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway. , 1997, Immunity.

[3]  Marek Kimmel,et al.  Stochastic regulation in early immune response. , 2006, Biophysical journal.

[4]  H. Ford,et al.  On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics , 2013, Oncogene.

[5]  R. Eils,et al.  Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis , 2004, The Journal of cell biology.

[6]  R. Milo,et al.  Variability and memory of protein levels in human cells , 2006, Nature.

[7]  Rui Wang,et al.  Modeling of the role of a Bax-activation switch in the mitochondrial apoptosis decision. , 2007, Biophysical journal.

[8]  M. Fussenegger,et al.  A mathematical model of caspase function in apoptosis , 2000, Nature Biotechnology.

[9]  Peter K. Sorger,et al.  Cells surviving fractional killing by TRAIL exhibit transient but sustainable resistance and inflammatory phenotypes , 2013, Molecular biology of the cell.

[10]  K. Fujimoto,et al.  Noisy signal amplification in ultrasensitive signal transduction. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Jochen H M Prehn,et al.  Systems analysis of effector caspase activation and its control by X‐linked inhibitor of apoptosis protein , 2006, The EMBO journal.

[12]  Wenhua Gao,et al.  Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. , 2003, Genes & development.

[13]  Guy S. Salvesen,et al.  SnapShot: Caspases , 2011, Cell.

[14]  Maike A. Laussmann,et al.  Proteasome Inhibition Can Impair Caspase-8 Activation upon Submaximal Stimulation of Apoptotic Tumor Necrosis Factor-related Apoptosis Inducing Ligand (TRAIL) Signaling* , 2012, The Journal of Biological Chemistry.

[15]  M. Rehm,et al.  Dynamics of outer mitochondrial membrane permeabilization during apoptosis , 2009, Cell Death and Differentiation.

[16]  Peter K Sorger,et al.  Modulating cell-to-cell variability and sensitivity to death ligands by co-drugging , 2013, Physical biology.

[17]  Timothy K Lee,et al.  Single-cell NF-κB dynamics reveal digital activation and analogue information processing , 2010, Nature.

[18]  Louise Fairall,et al.  A Death Effector Domain Chain DISC Model Reveals a Crucial Role for Caspase-8 Chain Assembly in Mediating Apoptotic Cell Death , 2012, Molecular cell.

[19]  P. Sorger,et al.  Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis , 2009, Nature.

[20]  M. El-Bahrawy,et al.  Selective CDK9 inhibition overcomes TRAIL resistance by concomitant suppression of cFlip and Mcl-1 , 2013, Cell Death and Differentiation.

[21]  Jochen H M Prehn,et al.  Systems analysis of BCL2 protein family interactions establishes a model to predict responses to chemotherapy. , 2013, Cancer research.

[22]  Seeun Oh,et al.  TRAIL-induced caspase/p38 activation is responsible for the increased catalytic and invasive activities of Akt. , 2010, International journal of oncology.

[23]  R. Milo,et al.  Oscillations and variability in the p53 system , 2006, Molecular systems biology.

[24]  Felix Naef,et al.  Stimulus-induced modulation of transcriptional bursting in a single mammalian gene , 2013, Proceedings of the National Academy of Sciences.

[25]  C. Rauch,et al.  Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo , 1999, Nature Medicine.

[26]  A. Arkin,et al.  Stochastic mechanisms in gene expression. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[27]  E. Solary,et al.  TRAIL-R4 Promotes Tumor Growth and Resistance to Apoptosis in Cervical Carcinoma HeLa Cells through AKT , 2011, PloS one.

[28]  S. Varadarajan,et al.  TRAIL-activated stress kinases suppress apoptosis through transcriptional upregulation of MCL-1 , 2010, Cell Death and Differentiation.

[29]  D. Tranchina,et al.  Stochastic mRNA Synthesis in Mammalian Cells , 2006, PLoS biology.

[30]  Douglas A Lauffenburger,et al.  Lyapunov exponents and phase diagrams reveal multi-factorial control over TRAIL-induced apoptosis , 2011, Molecular systems biology.

[31]  Roland Eils,et al.  Dynamics within the CD95 death-inducing signaling complex decide life and death of cells , 2010, Molecular systems biology.

[32]  Nils Blüthgen,et al.  Mathematical Modeling Identifies Inhibitors of Apoptosis as Mediators of Positive Feedback and Bistability , 2006, PLoS Comput. Biol..

[33]  John E. Eriksson,et al.  Rapid Turnover of c-FLIPshort Is Determined by Its Unique C-terminal Tail* , 2005, Journal of Biological Chemistry.

[34]  Nacho Molina,et al.  Mammalian Genes Are Transcribed with Widely Different Bursting Kinetics , 2011, Science.

[35]  C A Smith,et al.  Identification and characterization of a new member of the TNF family that induces apoptosis. , 1995, Immunity.

[36]  Susanne J. Braeuer,et al.  Constitutively Activated Nuclear Factor-κB, but not Induced NF-κB, Leads to TRAIL Resistance by Up-Regulation of X-Linked Inhibitor of Apoptosis Protein in Human Cancer Cells , 2006, Molecular Cancer Research.

[37]  Jin Wang,et al.  Intrinsic noise, dissipation cost, and robustness of cellular networks: The underlying energy landscape of MAPK signal transduction , 2008, Proceedings of the National Academy of Sciences.

[38]  Inna N Lavrik,et al.  Stoichiometry of the CD95 death-inducing signaling complex: experimental and modeling evidence for a death effector domain chain model. , 2012, Molecular cell.

[39]  G. Beslon,et al.  Quantifying the contribution of chromatin dynamics to stochastic gene expression reveals long, locus-dependent periods between transcriptional bursts , 2013, BMC Biology.

[40]  D. Lauffenburger,et al.  Modeling a Snap-Action, Variable-Delay Switch Controlling Extrinsic Cell Death , 2008, PLoS biology.

[41]  Peter K. Sorger,et al.  Exploring the Contextual Sensitivity of Factors that Determine Cell-to-Cell Variability in Receptor-Mediated Apoptosis , 2012, PLoS Comput. Biol..

[42]  Pawel Paszek,et al.  Modeling Stochasticity in Gene Regulation: Characterization in the Terms of the Underlying Distribution Function , 2007, Bulletin of mathematical biology.

[43]  Leor S Weinberger,et al.  Dynamics of protein noise can distinguish between alternate sources of gene-expression variability , 2012, Molecular systems biology.

[44]  Christoph H Emmerich,et al.  TRAIL signalling: decisions between life and death. , 2007, The international journal of biochemistry & cell biology.

[45]  Marc S. Sherman,et al.  A Computational Framework for Analyzing Stochasticity in Gene Expression , 2014, PLoS Comput. Biol..

[46]  Frank Allgöwer,et al.  Heterogeneity reduces sensitivity of cell death for TNF-Stimuli , 2011, BMC Systems Biology.

[47]  Brian Munsky,et al.  Listening to the noise: random fluctuations reveal gene network parameters , 2009, Molecular systems biology.

[48]  Marek Kimmel,et al.  Single TNFα trimers mediating NF-κB activation: stochastic robustness of NF-κB signaling , 2007, BMC Bioinformatics.

[49]  K. Verstrepen,et al.  Timescales of Genetic and Epigenetic Inheritance , 2007, Cell.

[50]  M. Fussenegger,et al.  Streptogramin-based gene regulation systems for mammalian cells , 2000, Nature Biotechnology.

[51]  Michael L. Simpson,et al.  Transcriptional burst frequency and burst size are equally modulated across the human genome , 2012, Proceedings of the National Academy of Sciences.

[52]  J. Raser,et al.  Noise in Gene Expression: Origins, Consequences, and Control , 2005, Science.

[53]  M. Khammash,et al.  Systematic Identification of Signal-Activated Stochastic Gene Regulation , 2013, Science.

[54]  Mark J. Smyth,et al.  The TRAIL apoptotic pathway in cancer onset, progression and therapy , 2008, Nature Reviews Cancer.